Anagyrine-induced red cell aplasia, vascular anomaly, and skeletal dysplasia.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000328:Adult; D000470:Alkaloids / Q000009:adverse effects*; D000818:Animals; D001392:Azocines; D001401:Azygos Vein / Q000002:abnormalities*; D001856:Bone Marrow Examination; D004480:Ectromelia / Q000209:etiology*; D005260:Female; D005506:Food Contamination; D006041:Goats; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D008892:Milk / Q000009:adverse effects; D010939:Plant Poisoning; D011247:Pregnancy; D011807:Quinolizines; D012010:Red-Cell Aplasia, Pure / Q000139:chemically induced / Q000209:etiology*; D014682:Vena Cava, Inferior / Q000002:abnormalities*; D000093843:Quinolizidine Alkaloids
D000470:Alkaloids; D001392:Azocines; D011807:Quinolizines; C012736:anagyrine; D000093843:Quinolizidine Alkaloids